Category - Pharma Industry News
NICE sticks to Zytiga rejection
NIHR/MRC fund new study of potential genetic roots of ME
NICE rejects Novartis’ Mayzent for secondary progressive MS
CHMP backs approval of remdesivir as COVID-19 treatment
CSL licenses uniQure haemophila B gene therapy in $2bn-plus deal
FDA approval for Merck’s Keytruda threatens Libtayo in skin cancer
Breztri Aerosphere cut rate of COPD exacerbations in PhIII trial
New consortium will monitor safety/efficacy of COVID-19 vaccines